Related Experiment Video
Updated: Nov 14, 2025
07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.2K
A framework for graduate and postgraduate specialty pharmacy training
Joseph L Cesarz1, David A Mott2, Eric D Friestrom3
1Visante, Inc, St. Paul, MN, USA.
Summary
A partnership between a health system and pharmacy school created a specialty pharmacy elective and residency program. This collaboration addresses the demand for pharmacy leaders in integrated delivery networks (IDNs).
Area of Science:
- Pharmacy Education
- Healthcare Leadership
- Specialty Pharmacy Practice
Background:
- There is a significant and growing demand for skilled specialty pharmacy leaders within integrated delivery networks (IDNs).
- Traditional pharmacy education and residency programs have not adequately prepared professionals to meet this demand.
- This gap highlights the need for innovative educational and training models.
Purpose of the Study:
- To describe a collaborative initiative between UW Health (UWH) and the University of Wisconsin School of Pharmacy (UWSOP).
- To detail the development of a specialty pharmacy elective course and a postgraduate residency training program.
- To explore future directions for this partnership in addressing the need for pharmacy leaders.
Main Methods:
- A partnership was established between UWH and UWSOP leadership to expand specialty pharmacy education.
- A 2-credit elective course focusing on business fundamentals, economics, and practice development was created at UWSOP.
- A postgraduate residency program was developed at UWH, offering comprehensive training in specialty pharmacy operations and leadership.
Main Results:
- The UWSOP elective course, launched in spring 2017, provided students with foundational knowledge in specialty pharmacy.
- The UWH residency program, initiated in 2013 and accredited in 2016, offers hands-on experience in leadership, managed care, finance, and supply chain.
- The partnership has successfully created educational pathways for students and postgraduate trainees.
Conclusions:
- This collaboration effectively bridges the gap between academic training and the practical needs of integrated delivery networks for specialty pharmacy leaders.
- Partnerships between health systems and schools of pharmacy are crucial for expanding educational opportunities and fulfilling market demands.
- The initiative provides a model for developing future leaders in the evolving field of specialty pharmacy.
More Related Videos
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
4.0K
12:54Density Gradient Multilayered Polymerization DGMP: A Novel Technique for Creating Multi-compartment, Customizable Scaffolds for Tissue Engineering
Published on: February 12, 2013
12.8K
Related Concept Videos
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.9K
01:26Drug Administration and Therapy Phases: Overview
958
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
958
01:28Preclinical Development: Overview
5.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.5K
01:19Pharmacovigilance
1.4K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.4K
01:24Dosage Regimen: Individualization
68
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
68
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
74
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
74